{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:42:37Z","timestamp":1789123357315,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s41030-026-00380-z","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:03Z","timestamp":1788417903000},"page":"869-884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-1860","authenticated-orcid":false,"given":"Helen","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro N.","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus W.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"5","key":"380_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716\u201325.","journal-title":"Nat Med"},{"key":"380_CR2","volume-title":"Global strategy for asthma management and prevention","author":"Global Initative for Asthma (GINA)","year":"2025","unstructured":"Global Initative for Asthma (GINA). Global strategy for asthma management and prevention. Global Initiative for Asthma; 2025."},{"issue":"10379","key":"380_CR3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","volume":"401","author":"C Porsbjerg","year":"2023","unstructured":"Porsbjerg C, Mel\u00e9n E, Lehtim\u00e4ki L, Shaw D. Asthma. Lancet. 2023;401(10379):858\u201373.","journal-title":"Lancet"},{"key":"380_CR4","unstructured":"Global Initative for Asthma (GINA). Difficult-to-treat & severe asthma in adolescent and adult patients. Fontana, WI; 2024."},{"issue":"8","key":"380_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/02770903.2018.1499035","volume":"56","author":"C Melero Moreno","year":"2019","unstructured":"Melero Moreno C, Quirce S, Huerta A, Ur\u00eda E, Cuesta M. Economic impact of severe asthma in Spain: multicentre observational longitudinal study. J Asthma. 2019;56(8):861\u201371.","journal-title":"J Asthma"},{"issue":"1","key":"380_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002003","volume":"10","author":"A Jacobs","year":"2023","unstructured":"Jacobs A, Wu R, Tomini F, De Simoni A, Mihaylova B. Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK. BMJ Open Respir Res. 2023;10(1):e002003.","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"380_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaip.2024.01.023","volume":"12","author":"A Bourdin","year":"2024","unstructured":"Bourdin A, Brusselle G, Couillard S, Fajt ML, Heaney LG, Israel E, et\u00a0al. Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics. J Allergy Clin Immunol: In Pract. 2024;12(4):809\u201323.","journal-title":"J Allergy Clin Immunol: In Pract"},{"issue":"11","key":"380_CR8","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/biomedicines9111684","volume":"9","author":"FLM Ricciardolo","year":"2021","unstructured":"Ricciardolo FLM, Sprio AE, Baroso A, Gallo F, Riccardi E, Bertolini F, et\u00a0al. Characterization of T2-low and T2-high asthma phenotypes in real-life. Biomedicines. 2021;9(11):1684.","journal-title":"Biomedicines"},{"key":"380_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2026.02.006","author":"I Agache","year":"2026","unstructured":"Agache I, Li S, Zheng Y, Gao Y. Asthma endotypes and theratypes. Chin Med J Pulm Crit Care Med. 2026. https:\/\/doi.org\/10.1016\/j.pccm.2026.02.006.","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"4","key":"380_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaci.2020.08.011","volume":"146","author":"S Miethe","year":"2020","unstructured":"Miethe S, Karsonova A, Karaulov A, Renz H. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"380_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","volume":"141","author":"U Peters","year":"2018","unstructured":"Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141(4):1169\u201379.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"380_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1001\/jama.2025.24288","volume":"335","author":"F Celletti","year":"2026","unstructured":"Celletti F, Farrar J, De Regil L. World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults. JAMA. 2026;335(5):434.","journal-title":"JAMA"},{"key":"380_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0000000000001249","author":"H O\u2019Brien","year":"2026","unstructured":"O\u2019Brien H, Franciosi AN, Butler MW. GLP-1 receptor agonists in asthma: targeting metabolic-inflammatory crossroads. Curr Opin Pulm Med. 2026. https:\/\/doi.org\/10.1097\/mcp.0000000000001249.","journal-title":"Curr Opin Pulm Med"},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1016\/j.jaip.2025.07.041","volume":"13","author":"S Gonem","year":"2025","unstructured":"Gonem S, Redmond C, Busby J, Patel P, Jackson DJ, Mansur AH, et\u00a0al. Effects of obesity on response to asthma biologic treatment: longitudinal data from the United Kingdom Severe Asthma Registry. J Allergy Clin Immunol: In Pract. 2025;13:3002\u201310.","journal-title":"J Allergy Clin Immunol: In Pract"},{"issue":"7","key":"380_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1164\/rccm.200611-1717OC","volume":"175","author":"DA Beuther","year":"2007","unstructured":"Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma. Am J Respir Crit Care Med. 2007;175(7):661\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"380_CR16","doi-asserted-by":"publisher","first-page":"2000612","DOI":"10.1183\/13993003.00612-2020","volume":"57","author":"CA Thompson","year":"2021","unstructured":"Thompson CA, Eslick SR, Berthon BS, Wood LG. Asthma medication use in obese and healthy weight asthma: systematic review\/meta-analysis. Eur Respir J. 2021;57(3):2000612.","journal-title":"Eur Respir J"},{"issue":"10","key":"380_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11882-019-0877-z","volume":"19","author":"A Mohan","year":"2019","unstructured":"Mohan A, Grace J, Wang BR, Lugogo N. The effects of obesity in asthma. Curr Allergy Asthma Rep. 2019;19(10):49.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"380_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jaci.2010.12.010","volume":"127","author":"E Forno","year":"2011","unstructured":"Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celed\u00f3n JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127(3):741\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"380_CR19","doi-asserted-by":"publisher","first-page":"00309","DOI":"10.1183\/23120541.00309-2020","volume":"7","author":"C Kyriakopoulos","year":"2021","unstructured":"Kyriakopoulos C, Gogali A, Bartziokas K, Kostikas K. Identification and treatment of T2-low asthma in the era of biologics. ERJ Open Res. 2021;7(2):00309\u20132020.","journal-title":"ERJ Open Res"},{"key":"380_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/JAA.S125948","volume":"11","author":"T Hirano","year":"2018","unstructured":"Hirano T, Matsunaga K. Late-onset asthma: current perspectives. J Asthma Allergy. 2018;11:19\u201327.","journal-title":"J Asthma Allergy"},{"key":"380_CR21","doi-asserted-by":"publisher","first-page":"1315540","DOI":"10.3389\/fphar.2023.1315540","volume":"14","author":"D Garg","year":"2024","unstructured":"Garg D, Que LG, Ingram JL. Effects of biological therapies on patients with type-2 high asthma and comorbid obesity. Front Pharmacol. 2024;14:1315540.","journal-title":"Front Pharmacol"},{"issue":"1","key":"380_CR22","doi-asserted-by":"publisher","first-page":"220263","DOI":"10.1183\/20734735.0263-2022","volume":"19","author":"NM Shah","year":"2023","unstructured":"Shah NM, Kaltsakas G. Respiratory complications of obesity: from early changes to respiratory failure. Breath (Sheff). 2023;19(1):220263.","journal-title":"Breath (Sheff)"},{"issue":"11","key":"380_CR23","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.jaip.2021.09.003","volume":"9","author":"MD Althoff","year":"2021","unstructured":"Althoff MD, Ghincea A, Wood LG, Holguin F, Sharma S. Asthma and three colinear comorbidities: obesity, OSA, and GERD. J Allergy Clin Immunol Pract. 2021;9(11):3877\u201384.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"380_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hgmx.2016.06.011","volume":"80","author":"AM Castro","year":"2017","unstructured":"Castro AM, Macedo-De La Concha LE, Pantoja-Mel\u00e9ndez CA. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Revista M\u00e9dica del Hospital General de M\u00e9xico. 2017;80(2):101\u20135.","journal-title":"Revista M\u00e9dica del Hospital General de M\u00e9xico."},{"issue":"2","key":"380_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jaci.2014.12.1931","volume":"136","author":"K Hasegawa","year":"2015","unstructured":"Hasegawa K, Tsugawa Y, Chang Y, Camargo CA. Risk of an asthma exacerbation after bariatric surgery in adults. J Allergy Clin Immunol. 2015;136(2):288-94.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"380_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.10.014","author":"A Rybka-Fraczek","year":"2025","unstructured":"Rybka-Fraczek A, Orzolek I, Dabrowska M. Effect of weight loss on asthma in obese adult patients with asthma\u2014a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2025. https:\/\/doi.org\/10.1016\/j.jaip.2025.10.014.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"380_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13527","author":"L Xie","year":"2023","unstructured":"Xie L, Chandrasekhar A, Desantis SM, Almandoz JP, De La Cruz\u2010Mu\u00f1oz N, Messiah SE. Discontinuation and reduction of asthma medications after metabolic and bariatric surgery: a systematic review and meta\u2010analysis. Obes Rev. 2023. https:\/\/doi.org\/10.1111\/obr.13527.","journal-title":"Obes Rev"},{"issue":"6","key":"380_CR28","first-page":"607","volume":"37","author":"M Zhang","year":"2024","unstructured":"Zhang M, Lin C, Cai X, Jiao R, Bai S, Li Z, et\u00a0al. The association between GLP-1 receptor-based agonists and the incidence of asthma in patients with type 2 diabetes and\/or obesity: a meta-analysis. Biomed Environ Sci. 2024;37(6):607.","journal-title":"Biomed Environ Sci"},{"issue":"9","key":"380_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1164\/rccm.202112-2745OC","volume":"206","author":"MC Peters","year":"2022","unstructured":"Peters MC, Schiebler ML, Cardet JC, Johansson MW, Sorkness R, Deboer MD, et\u00a0al. The impact of insulin resistance on loss of lung function and response to treatment in asthma. Am J Respir Crit Care Med. 2022;206(9):1096\u2013106.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"380_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020437","volume":"12","author":"K Bartziokas","year":"2024","unstructured":"Bartziokas K, Papaioannou AI, Drakopanagiotakis F, Gouveri E, Papanas N, Steiropoulos P. Unraveling the link between insulin resistance and bronchial asthma. Biomedicines. 2024;12(2):437.","journal-title":"Biomedicines"},{"key":"380_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et\u00a0al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020. https:\/\/doi.org\/10.3389\/fphys.2019.01607.","journal-title":"Front Physiol"},{"issue":"9","key":"380_CR32","doi-asserted-by":"publisher","first-page":"L837","DOI":"10.1152\/ajplung.00091.2015","volume":"310","author":"S Singh","year":"2016","unstructured":"Singh S, Bodas M, Bhatraju NK, Pattnaik B, Gheware A, Parameswaran PK, et\u00a0al. Hyperinsulinemia adversely affects lung structure and function. Am J Physiol-Lung Cell Mol Physiol. 2016;310(9):L837\u201345.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"11","key":"380_CR33","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1016\/j.jaip.2021.07.007","volume":"9","author":"TD Wu","year":"2021","unstructured":"Wu TD, Fawzy A, Akenroye A, Keet C, Hansel NN, McCormack MC. Metformin use and risk of asthma exacerbation among asthma patients with glycemic dysfunction. J Allergy Clin Immunol Pract. 2021;9(11):4014-20.e4.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"380_CR34","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.3390\/nu5093506","volume":"5","author":"H Periyalil","year":"2013","unstructured":"Periyalil H, Gibson P, Wood L. Immunometabolism in obese asthmatics: are we there yet? Nutrients. 2013;5(9):3506\u201330.","journal-title":"Nutrients"},{"issue":"1","key":"380_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","volume":"32","author":"S Sun","year":"2012","unstructured":"Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr. 2012;32(1):261\u201386.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"380_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"380_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000324","volume":"5","author":"J Jo","year":"2009","unstructured":"Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, et\u00a0al. Hypertrophy and\/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol. 2009;5(3):e1000324.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"380_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","volume":"23","author":"C Pic\u00f3","year":"2022","unstructured":"Pic\u00f3 C, Palou M, Pomar CA, Rodr\u00edguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23(1):13\u201330.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"380_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J-I, et\u00a0al. Paradoxical decrease of an adipose-specific protein, adiponectin. Obes Biochem Biophys Res Commun. 1999;257(1):79\u201383.","journal-title":"Obes Biochem Biophys Res Commun"},{"issue":"1-2","key":"380_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380(1\u20132):24\u201330.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"380_CR41","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796\u2013808.","journal-title":"J Clin Invest"},{"issue":"1","key":"380_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s41030-024-00281-z","volume":"11","author":"D Adair","year":"2025","unstructured":"Adair D, Bagheri A, Yosef M, Khalatbari S, Lewis T, Mohan A, et\u00a0al. High interleukin (IL)-6 is associated with lower lung function and increased likelihood of metabolic dysfunction in asthma. Pulm Ther. 2025;11(1):41\u201354.","journal-title":"Pulm Ther"},{"key":"380_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.718929","author":"H Salvator","year":"2021","unstructured":"Salvator H, Grassin-Delyle S, Brollo M, Couderc L-J, Abrial C, Victoni T, et\u00a0al. Adiponectin inhibits the production of TNF-\u03b1, IL-6 and chemokines by human lung macrophages. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.718929.","journal-title":"Front Pharmacol"},{"key":"380_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977485","author":"J Yao","year":"2022","unstructured":"Yao J, Wu D, Qiu Y. Adipose tissue macrophage in obesity-associated metabolic diseases. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.977485.","journal-title":"Front Immunol"},{"issue":"3","key":"380_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4093\/dmj.2018.0221","volume":"43","author":"C-Y Woo","year":"2019","unstructured":"Woo C-Y, Jang JE, Lee SE, Koh EH, Lee K-U. Mitochondrial dysfunction in adipocytes as a primary cause of adipose tissue inflammation. Diabetes Metab J. 2019;43(3):247.","journal-title":"Diabetes Metab J"},{"key":"380_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149366","author":"D Pan","year":"2023","unstructured":"Pan D, Li G, Jiang C, Hu J, Hu X. Regulatory mechanisms of macrophage polarization in adipose tissue. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1149366.","journal-title":"Front Immunol"},{"issue":"2","key":"380_CR47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1096\/fj.14-253831","volume":"29","author":"CMW Van Stijn","year":"2015","unstructured":"Van Stijn CMW, Kim J, Lusis AJ, Barish GD, Tangirala RK. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response. FASEB J. 2015;29(2):636\u201349.","journal-title":"FASEB J"},{"key":"380_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/omcl\/6710641","author":"KF Hinojosa Vera","year":"2025","unstructured":"Hinojosa Vera KF, Hemakumar C, Bilachi RS, Ramirez DC, Gomez Mejiba SE. Macrophage phenotypic switch and obesity\u2010associated metabolic risk: mechanisms and targets. Oxid Med Cell Longev. 2025. https:\/\/doi.org\/10.1155\/omcl\/6710641.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"380_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/02770903.2022.2051548","volume":"60","author":"V Sharma","year":"2023","unstructured":"Sharma V, Ricketts HC, Steffensen F, Goodfellow A, Cowan DC. Obesity affects type 2 biomarker levels in asthma. J Asthma. 2023;60(2):385\u201392.","journal-title":"J Asthma"},{"key":"380_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae039","author":"PM Huynh","year":"2025","unstructured":"Huynh PM, Wang F, An YA. Hypoxia signaling in the adipose tissue. J Mol Cell Biol. 2025. https:\/\/doi.org\/10.1093\/jmcb\/mjae039.","journal-title":"J Mol Cell Biol"},{"key":"380_CR51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63852","author":"M Basheeruddin","year":"2024","unstructured":"Basheeruddin M, Qausain S. Hypoxia-inducible factor 1-alpha (HIF-1\u03b1): an essential regulator in cellular metabolic control. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.63852.","journal-title":"Cureus"},{"issue":"6","key":"380_CR52","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","volume":"157","author":"Y Lee","year":"2014","unstructured":"Lee Y, Kim JW, Osborne O, Oh DY, Sasik R, Schenk S, et\u00a0al. Increased adipocyte O2 consumption triggers HIF-1\u03b1, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339\u201352.","journal-title":"Cell"},{"issue":"11","key":"380_CR53","doi-asserted-by":"publisher","first-page":"9409","DOI":"10.18632\/oncotarget.3352","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Zhu Y, Wang X, Gong J, Hu C, Guo B, et\u00a0al. Temporal regulation of HIF-1 and NF-\u03baB in hypoxic hepatocarcinoma cells. Oncotarget. 2015;6(11):9409\u201319.","journal-title":"Oncotarget"},{"issue":"5","key":"380_CR54","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.5.804","volume":"49","author":"JH Shin","year":"2008","unstructured":"Shin JH, Kim JH, Lee WY, Shim JY. The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells. Yonsei Med J. 2008;49(5):804.","journal-title":"Yonsei Med J"},{"issue":"7","key":"380_CR55","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.201203-0573OC","volume":"186","author":"O Sideleva","year":"2012","unstructured":"Sideleva O, Suratt BT, Black KE, Tharp WG, Pratley RE, Forgione P, et\u00a0al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186(7):598\u2013605.","journal-title":"Am J Respir Crit Care Med"},{"key":"380_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2026.100449","volume":"29","author":"VE Georgakopoulou","year":"2026","unstructured":"Georgakopoulou VE, Dalamaga M. GLP-1 receptor agonists and obstructive lung disease: beyond metabolic control to respiratory outcomes. Metab Open. 2026;29:100449.","journal-title":"Metab Open"},{"key":"380_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2147\/JAA.S402340","volume":"16","author":"HR Kim","year":"2023","unstructured":"Kim HR, Ingram JL, Que LG. Effects of oxidative stress on airway epithelium permeability in asthma and potential implications for patients with comorbid obesity. J Asthma Allergy. 2023;16:481\u201399.","journal-title":"J Asthma Allergy"},{"issue":"21","key":"380_CR58","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1007\/s00018-018-2899-4","volume":"75","author":"M Michalik","year":"2018","unstructured":"Michalik M, W\u00f3jcik-Pszczo\u0142a K, Paw M, Wnuk D, Koczurkiewicz P, Sanak M, et\u00a0al. Fibroblast-to-myofibroblast transition in bronchial asthma. Cell Mol Life Sci. 2018;75(21):3943\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"380_CR59","doi-asserted-by":"publisher","first-page":"L419","DOI":"10.1152\/ajplung.00208.2025","volume":"330","author":"N Jalaleddine","year":"2026","unstructured":"Jalaleddine N, Hachim M, Giddey A, Gaudet M, Hamid Q, Uddin M, et\u00a0al. Obese adipocytes induce fibroblast-to-myofibroblast transition through TGF-\u03b21 signaling: implications in asthma pathogenesis. Am J Physiol-Lung Cell Mol Physiol. 2026;330(4):L419\u201330.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"1","key":"380_CR60","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et\u00a0al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234.","journal-title":"Signal Transduct Target Ther"},{"key":"380_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.101895","volume":"14","author":"TM Al-Noshokaty","year":"2025","unstructured":"Al-Noshokaty TM, Abdelhamid R, Abdelmaksoud NM, Khaled A, Hossam M, Ahmed R, et\u00a0al. Unlocking the multifaceted roles of GLP-1: physiological functions and therapeutic potential. Toxicol Rep. 2025;14:101895.","journal-title":"Toxicol Rep"},{"issue":"4","key":"380_CR62","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740\u201356.","journal-title":"Cell Metab"},{"key":"380_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller TD, Finan B, Bloom SR, D\u2019Alessio D, Drucker DJ, Flatt PR, et\u00a0al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72\u2013130.","journal-title":"Mol Metab"},{"issue":"4","key":"380_CR64","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/en.2013-1934","volume":"155","author":"C Pyke","year":"2014","unstructured":"Pyke C, Heller RS, Kirk RK, \u00d8rskov C, Reedtz-Runge S, Kaastrup P, et\u00a0al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 2014;155(4):1280\u201390.","journal-title":"Endocrinology"},{"issue":"2","key":"380_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbrc.2020.01.081","volume":"524","author":"H Nohara","year":"2020","unstructured":"Nohara H, Nakashima R, Kamei S, Fujikawa H, Ueno-Shuto K, Kawakami T, et\u00a0al. Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases. Biochem Biophys Res Commun. 2020;524(2):332\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"380_CR66","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/mmr.2017.6618","volume":"16","author":"Y-H Sun","year":"2017","unstructured":"Sun Y-H, He L, Yan M-Y, Zhao R-Q, Li B, Wang F, et\u00a0al. Overexpression of GLP-1 receptors suppresses proliferation and cytokine release by airway smooth muscle cells of patients with chronic obstructive pulmonary disease via activation of ABCA1. Mol Med Rep. 2017;16(1):929\u201336.","journal-title":"Mol Med Rep"},{"key":"380_CR67","doi-asserted-by":"crossref","unstructured":"Lehman C, Peebles Jr RS. The therapeutic potential of glucagon-like peptide-1 receptor analogs for neuroinflammation in the setting of asthma. Explor Asthma Allergy. 2025;3100967.","DOI":"10.37349\/eaa.2025.100967"},{"issue":"4","key":"380_CR68","doi-asserted-by":"publisher","first-page":"jjae160","DOI":"10.1093\/ecco-jcc\/jjae160","volume":"19","author":"Y Gorelik","year":"2025","unstructured":"Gorelik Y, Ghersin I, Lujan R, Shlon D, Loewenberg Weisband Y, Ben-Tov A, et\u00a0al. GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN. J Crohn\u2019s and Colitis. 2025;19(4):jjae160.","journal-title":"J Crohn\u2019s and Colitis"},{"issue":"9","key":"380_CR69","doi-asserted-by":"publisher","first-page":"e70103","DOI":"10.1002\/acr2.70103","volume":"7","author":"DA Kellner","year":"2025","unstructured":"Kellner DA, Dente E, Tran V, Welsh T, Tran V, Saha A, et\u00a0al. Effect of glucagon-like peptide 1 receptor agonists on patients with rheumatoid arthritis. ACR Open Rheumatol. 2025;7(9):e70103.","journal-title":"ACR Open Rheumatol"},{"issue":"9","key":"380_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103864","volume":"24","author":"E Bilgin","year":"2025","unstructured":"Bilgin E, Venerito V, Bogdanos DP. Glucagon-like peptide-1 (GLP-1) receptor agonists in rheumatology: a review of current evidence and future directions. Autoimmun Rev. 2025;24(9):103864.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"380_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153\u201365.","journal-title":"Cell Metab"},{"issue":"4","key":"380_CR72","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409\u201339.","journal-title":"Physiol Rev"},{"key":"380_CR73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2019.04.010","volume":"128","author":"NK Smith","year":"2019","unstructured":"Smith NK, Hackett TA, Galli A, Flynn CR. GLP-1: molecular mechanisms and outcomes of a complex signaling system. Neurochem Int. 2019;128:94\u2013105.","journal-title":"Neurochem Int"},{"key":"380_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170749","volume":"151","author":"A Mayendraraj","year":"2022","unstructured":"Mayendraraj A, Rosenkilde MM, Gasbjerg LS. GLP-1 and GIP receptor signaling in beta cells\u2014a review of receptor interactions and co-stimulation. Peptides. 2022;151:170749.","journal-title":"Peptides"},{"key":"380_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","volume":"7","author":"VK Raker","year":"2016","unstructured":"Raker VK, Becker C, Steinbrink K. The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases. Front Immunol. 2016;7:123.","journal-title":"Front Immunol"},{"issue":"4","key":"380_CR76","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","volume":"57","author":"AE Hogan","year":"2014","unstructured":"Hogan AE, Gaoatswe G, Lynch L, Corrigan MA, Woods C, O\u2019Connell J, et\u00a0al. Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. Diabetologia. 2014;57(4):781\u20134.","journal-title":"Diabetologia"},{"issue":"7","key":"380_CR77","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1111\/dom.16366","volume":"27","author":"Y Ren","year":"2025","unstructured":"Ren Y, Chen Y, Zheng W, Kong W, Liao Y, Zhang J, et\u00a0al. The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2025;27(7):3607\u201326.","journal-title":"Diabetes Obes Metab"},{"issue":"11\/12","key":"380_CR78","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1055\/s-2004-826160","volume":"36","author":"CF Deacon","year":"2004","unstructured":"Deacon CF. Circulation and degradation of GIP and GLP-1. Horm Metab Res. 2004;36(11\/12):761\u20135.","journal-title":"Horm Metab Res"},{"issue":"5","key":"380_CR79","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/ijcp.12361","volume":"68","author":"S Brunton","year":"2014","unstructured":"Brunton S. GLP\u20101 receptor agonists vs. DPP\u20104 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Int J Clin Pract. 2014;68(5):557\u201367.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"380_CR80","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jaci.2017.11.043","volume":"142","author":"S Toki","year":"2018","unstructured":"Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, et\u00a0al. Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in\u00a0vivo. J Allergy Clin Immunol. 2018;142(5):1515-28.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"380_CR81","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1111\/all.14879","volume":"76","author":"S Toki","year":"2021","unstructured":"Toki S, Newcomb DC, Printz RL, Cahill KN, Boyd KL, Niswender KD, et\u00a0al. Glucagon\u2010like peptide\u20101 receptor agonist inhibits aeroallergen\u2010induced activation of ILC2 and neutrophilic airway inflammation in obese mice. Allergy. 2021;76(11):3433\u201345.","journal-title":"Allergy"},{"issue":"4","key":"380_CR82","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41385-020-0262-1","volume":"13","author":"W Choi","year":"2020","unstructured":"Choi W, Choe S, Lin J, Borchers MT, Kosmider B, Vassallo R, et\u00a0al. Exendin-4 restores airway mucus homeostasis through the GLP1R-PKA-PPAR\u03b3-FOXA2-phosphatase signaling. Mucosal Immunol. 2020;13(4):637\u201351.","journal-title":"Mucosal Immunol"},{"issue":"3","key":"380_CR83","doi-asserted-by":"publisher","first-page":"E568","DOI":"10.1152\/ajpendo.00292.2020","volume":"319","author":"W Zhou","year":"2020","unstructured":"Zhou W, Shao W, Zhang Y, Liu D, Liu M, Jin T. Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein. Am J Physiol Endocrinol Metab. 2020;319(3):E568\u201378.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"380_CR84","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1038\/s41598-020-74912-1","volume":"10","author":"J Fandi\u00f1o","year":"2020","unstructured":"Fandi\u00f1o J, Toba L, Gonz\u00e1lez-Mat\u00edas LC, Diz-Chaves Y, Mallo F. GLP-1 receptor agonist ameliorates experimental lung fibrosis. Sci Rep. 2020;10(1):18091.","journal-title":"Sci Rep"},{"issue":"1","key":"380_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne LJ, Horn DB, Le Roux CW, Ho W, Falcon BL, Gomez Valderas E, et\u00a0al. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393(1):26\u201336.","journal-title":"N Engl J Med"},{"issue":"6","key":"380_CR86","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kaplan LM, Fr\u00edas JP, Wu Q, Du Y, Gurbuz S, et\u00a0al. Triple\u2013hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial. N Engl J Med. 2023;389(6):514\u201326.","journal-title":"N Engl J Med"},{"issue":"9","key":"380_CR87","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00592-025-02534-y","volume":"62","author":"K Yan","year":"2025","unstructured":"Yan K, Yu H, Blaise B. Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalized type 2 diabetes care\u2014a systematic review and network meta-analysis. Acta Diabetol. 2025;62(9):1359\u201370.","journal-title":"Acta Diabetol"},{"key":"380_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103586","volume":"82","author":"T Sun","year":"2025","unstructured":"Sun T, Yu H, Zhang D, Zhang D, Li D, Fu J. Glucagon-like peptide-1 receptor signaling activation in alveolar type II cells enhances lung development in neonatal rats exposed to hyperoxia. Redox Biol. 2025;82:103586.","journal-title":"Redox Biol"},{"issue":"4","key":"380_CR89","doi-asserted-by":"publisher","first-page":"L374","DOI":"10.1152\/ajplung.1993.265.4.L374","volume":"265","author":"G Richter","year":"1993","unstructured":"Richter G, Feddersen O, Wagner U, Barth P, Goke R, Goke B. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol Lung Cell Mol Physiol. 1993;265(4):L374\u201381.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"380_CR90","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/cea.12860","volume":"47","author":"PD Mitchell","year":"2017","unstructured":"Mitchell PD, Salter BM, Oliveria JP, El-Gammal A, Tworek D, Smith SG, et\u00a0al. Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation. Clin Exp Allergy. 2017;47(3):331\u20138.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"380_CR91","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1007\/s12325-025-03175-x","volume":"42","author":"A Kaplan","year":"2025","unstructured":"Kaplan A, Heatley H, Townend J, Skinner D, Carter V, Hubbard R, et\u00a0al. The real-world impact of glucagon-like peptide 1 receptor agonists on asthma control in people with high-risk asthma and obesity. Adv Ther. 2025;42(6):2950\u20136.","journal-title":"Adv Ther"},{"issue":"11","key":"380_CR92","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1513\/AnnalsATS.202309-836OC","volume":"21","author":"T Wang","year":"2024","unstructured":"Wang T, Keil AP, Buse JB, Keet C, Kim S, Wyss R, et\u00a0al. Glucagon-like peptide 1 receptor agonists and asthma exacerbations: which patients benefit most? Ann Am Thorac Soc. 2024;21(11):1496\u2013506.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"380_CR93","doi-asserted-by":"publisher","first-page":"35625","DOI":"10.1038\/s41598-025-19657-5","volume":"15","author":"LT Ho","year":"2025","unstructured":"Ho LT, Fang YW, Hsu PS, Wang JT, Tsai MH. Association between glucagon-like peptide-1 receptor agonist therapy and respiratory illness in patients with type 2 diabetes: a retrospective observational cohort study. Sci Rep. 2025;15(1):35625.","journal-title":"Sci Rep"},{"key":"380_CR94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/COPD.S393323","volume":"18","author":"W Wang","year":"2023","unstructured":"Wang W, Mei A, Qian H, Li D, Xu H, Chen J, et\u00a0al. The role of glucagon-like peptide-1 receptor agonists in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2023;18:129\u201337.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"380_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13907","author":"MA Farhangi","year":"2025","unstructured":"Farhangi MA, Doumat G, Baroni IF, Camargo CA. Weight loss and asthma control: a systematic review of randomized controlled trials. Obes Rev. 2025. https:\/\/doi.org\/10.1111\/obr.13907.","journal-title":"Obes Rev"},{"issue":"6","key":"380_CR96","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/02770903.2011.587581","volume":"48","author":"C Lombardi","year":"2011","unstructured":"Lombardi C, Gargioni S, Gardinazzi A, Canonica GW, Passalacqua G. Impact of bariatric surgery on pulmonary function and nitric oxide in asthmatic and non-asthmatic obese patients. J Asthma. 2011;48(6):553\u20137.","journal-title":"J Asthma"},{"issue":"1","key":"380_CR97","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cea.12004","volume":"43","author":"HA Scott","year":"2013","unstructured":"Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ, Callister R, et\u00a0al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy. 2013;43(1):36\u201349.","journal-title":"Clin Exp Allergy"},{"key":"380_CR98","doi-asserted-by":"crossref","unstructured":"Ulrik C, Trunk-Black J, Ali, Nilas. Asthma and obesity: does weight loss improve asthma control? A systematic review. J Asthma and Allergy. 2012:21\u20136.","DOI":"10.2147\/JAA.S32232"},{"key":"380_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1613610","author":"X Xie","year":"2025","unstructured":"Xie X, Yang S, Deng S, Liu Y, Xu Z, He B. Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2025.1613610.","journal-title":"Front Pharmacol"},{"issue":"1","key":"380_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgae719","volume":"110","author":"RJ Jalleh","year":"2024","unstructured":"Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, et\u00a0al. Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. J Clin Endocrinol Metab. 2024;110(1):1\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"380_CR101","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00592-025-02611-2","volume":"63","author":"G Rossi","year":"2025","unstructured":"Rossi G, Bucciarelli L, Mananguite C-L, Giovarelli M, Fiorina P. Muscle loss and GLP-1R agonists use. Acta Diabetol. 2025;63(2):333\u201342.","journal-title":"Acta Diabetol"},{"key":"380_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112924","volume":"229","author":"D Pantazopoulos","year":"2025","unstructured":"Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N. GLP-1 receptor agonists and sarcopenia: weight loss at a cost? A brief narrative review. Diabetes Res Clin Pract. 2025;229:112924.","journal-title":"Diabetes Res Clin Pract"},{"key":"380_CR103","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-085304","volume":"392","author":"S West","year":"2026","unstructured":"West S, Scragg J, Aveyard P, Oke JL, Willis L, Haffner SJP, et\u00a0al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. Br Med J. 2026;392:e085304.","journal-title":"Br Med J"},{"issue":"3","key":"380_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030407","volume":"12","author":"EK Johnston","year":"2023","unstructured":"Johnston EK, Abbott RD. Adipose tissue paracrine-, autocrine-, and matrix-dependent signaling during the development and progression of obesity. Cells. 2023;12(3):407.","journal-title":"Cells"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-026-00380-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:02:23Z","timestamp":1789120943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-026-00380-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1007\/s41030-026-00380-z","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Helen O\u2019Brien, Adam J. Byrne, Alessandro N. Franciosi, and Marcus W. Butler all declare that they have no competing interests to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}